EDGAR Filing Documents for 0000950123-10-026333

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0000950123-10-026333

Filing Date

2010-03-19

Accepted

2010-03-19 14:36:08

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	g22569e10vk.htm	10-K	692069
2	EX-4.8	g22569exv4w8.htm	EX-4.8	47108
3	EX-23.1	g22569exv23w1.htm	EX-23.1	1594
4	EX-31.1	g22569exv31w1.htm	EX-31.1	7350
5	EX-31.2	g22569exv31w2.htm	EX-31.2	7384
6	EX-32.1	g22569exv32w1.htm	EX-32.1	3895
7	GRAPHIC	g22569g2256900.gif	GRAPHIC	12681
	Complete submission text file	0000950123-10-026333.txt		778406

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203

Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068

CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33637 | Film No.: 10693952
SIC: 2834 Pharmaceutical Preparations